MyAverix Finance
US · Healthcare
LakeShore Biopharma Co., Ltd (LSB)
Biotechnology
LakeShore Biopharma Co., Ltd (LSB) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-30, reported market cap is $25.84M, P/E ratio is 18.00, net margin is -16.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for LSB
LakeShore Biopharma Co., Ltd (LSB) — FAQ
What is LakeShore Biopharma Co., Ltd's market cap?
LakeShore Biopharma Co., Ltd (LSB) has a reported market cap of $25.84M (data as of 2026-03-30).
What is LSB's P/E ratio?
The price-to-earnings (P/E) ratio for LakeShore Biopharma Co., Ltd (LSB) is 18.00 (data as of 2026-03-30).
Does LakeShore Biopharma Co., Ltd pay a dividend?
Dividend yield is not available in the current snapshot for LakeShore Biopharma Co., Ltd (LSB). Check the MyAverix Finance app for the latest dividend data.
What sector is LakeShore Biopharma Co., Ltd in?
LakeShore Biopharma Co., Ltd (LSB) is classified in the Healthcare sector (Biotechnology industry).
What exchange is LSB listed on?
LSB is listed on US.
What is LakeShore Biopharma Co., Ltd's net margin?
LakeShore Biopharma Co., Ltd (LSB) reports a net margin of -16.3% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.